Canadian Patient Suffering from BPH, Undergoes a Urological Minimally Invasive Interventional Procedure
Recently, the Urological Surgery Department of our hospital received a 74 years old Canadian patient who complained of urinary incontinence and was diagnosed with Benign prostatic hyperplasia (BPH). The patient was under Dr. Wang Xiangwei, the Director of the Urological Surgery Department. After a thorough discussion about the treatment, he agreed to undergo prostatic artery embolization (PAE), minimally invasive surgery on the 5th of November. On the day of the operation, Director Wang Xiangwei invited colleagues from the International Medical Administration to the inpatient ward to help communicate with the patient.
The patient had a joyful conversation with the members of the International Medical Administration and informed them that it’s been 23 years since he settled down in Shenzhen with his wife. He used to work in the field of international trade and has retired now. Since feeling unwell, he has visited several hospitals and well-known clinics, but with no beneficial effect. However, after some research online, he learned about Director Wang Xiangwei's clinical success in treating BPH. Director Wang Xiangwei jointly with Dr.Tang Jun, director of the Intervention department of Southern University of Science and Technology Hospital, has treated several BPH patients using a minimally invasive surgical approach with high clinical success. To relieve the patient's anxiety, Dr. Atik from the International Medical Administration entered the operating room to comfort the patient and told him that the operation was in good condition. The patient has successfully recovered from the procedure and was happily discharged from the hospital within two days.
The Urological Surgery Director Wang Xiangwei has majored in minimally invasive procedures for 27 years, accumulatively completed more than 5000 cases of urological minimally invasive surgeries. Additionally, The Intervention Department Director Tang Jun has vast experience in the minimally invasive interventional procedures for treating various vascular diseases. At present，this minimally invasive procedure to treat male BPH performed by the Southern University of Science and Technology Hospital achieved great success and the patient expressed great satisfaction with his clinical and surgical procedure.
近日，我院泌尿外科收治了一位74岁的加拿大患者，他主诉尿失禁，被诊断为良性前列腺增生症（BPH）。患者由泌尿外科主任王祥卫医生主治。在对治疗进行彻底讨论后，他同意在11月5日接受前列腺动脉栓塞（PAE）微创手术。手术当天，王祥卫主任邀请国际医疗部的同事到住院病房与患者进行沟通。
患者与国际医疗部的成员进行了愉快的交谈，他提到与妻子在深圳定居已经23年了，过去在国际贸易领域工作，现在已经退休。由于身体不适，他访问了国内很多知名医院，但效果不佳。经过多方咨询、调研，他了解到南方科技大学医院王祥卫主任在治疗前列腺增生方面的临床成功。王祥卫主任与介入科唐俊主任联合使用了微创手术方法治疗BPH患者，取得了较好的临床效果。为缓解患者紧张情绪，手术进行过半时，国际医疗部的Atik博士进入手术室安慰患者，并告知手术情况良好。目前，患者已成功康复，并在两天内愉快地出院。
泌尿外科王祥卫主任主攻微创手术27年，累计完成泌尿外科微创手术5000余例。此外，介入科主任唐俊主任在治疗各种血管疾病的微创介入手术方面拥有丰富的经验。目前，南科大医院的这台治疗男性前列腺增生症的微创手术取得了巨大成功，患者对这次诊疗服务表示了极大的满意。
